E Greg McCartney insider trades: Genesis Bioventures (GBIW.OB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where E reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 15, 2006 | GBIW.OB | ↑ Buy | 2,213,281 | $458315.00 | $1014.38B | Direct | Feb 16, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About E Greg McCartney's insider trades
E Greg McCartney is CEO at Genesis Bioventures (GBIW.OB). Since Feb 15, 2006, E has reported 1 open-market purchase worth $1014.38B and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (21 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GBIW.OB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.